Bibliografická identifikace v angličtině Author's first name and surname: Lenka Boťchová, BA Title of the master thesis: Does status epilepticus during early postnatal period influence laboratory rat psychomotor development? Department: Department of Rehabilitation and Exercise Medicine Supervisor: doc. PharmDr. H. Kubová, DrSc. The year of presentation: 2013 Abstract: The purpose of this study is to evaluate the influence of status epilepticus (SE) in postnatal development early phase on laboratory rat psychomotor development. Experimentally caused (SE) is the most common mode of epileptogenesis, which is the process leading to the epilepsy creation, and typical comorbidities. The influence of the early SE was studied when using lithium/pilocarpine model of SE induced on 12 days old rat cubs, which were repeatedly exposed to the "open field" test until 32nd day of their lives that means until the puberty beginning. The evaluation is focused on cognition and overall locomotion changes and anxiety demonstrations. The results show that in short periods after SE (up to 1 month) the cognitive functions regarding the habituation disorder are not worsened. However, hyperactivity short-term disposition and worse adaptability to experimental conditions due to animal anxiety increase were detected. Motor skills of...

Patients with epilepsy often suffer debilitating cognitive and psycho-affective disorders.In some cases, epilepsy is associated to neurodegenerative processes that are the targetof certain therapeutical agents. Today, erythropoietin is considered as one of the most promising neuroprotective agents. In addition, an increased body of studies provides evidence that enrichment (or complexity) of housing decreases the cerebral vulnerabilityin the context of diverse brain insults. In this thesis, we demonstrate: 1) in a model ofepilepsy with large neuronal lesions, that erythropoietin protects the most vulnerable neuronal populations to excitotoxic injury, at the only condition that neuronal expression of its receptor is optimized prior to the primary insult causing epilepsy; 2) in a model of epilepsy associated with faint neuronal lesions that: i) erythropoietin prevents anxietyand impaired spatial learning and memory, ii) enriched housing in Marlau™ cages is moreefficient than erythropoietin, and iii) erythropoietin treatment abolishes beneficial effectsof enriched housing. These results, obtained in animal models of epilepsies associatedwith cognitive disorders establish that beneficial effects of a potential therapeutic agentmay rely on quality of life

Thesis (Ph.D.)--Virginia Commonwealth University, 2009. / Prepared for: Dept. of Pharmacology and Toxicology. Title from resource description page. Includes bibliographical references.

Submitted by Automa??o e Estat?stica (sst@bczm.ufrn.br) on 2017-10-04T23:54:47Z No. of bitstreams: 1 RafaelDosSantosDeBessa_DISSERT.pdf: 5392283 bytes, checksum: e272b2b1fcdcb6eb2e291aaaead851c7 (MD5) / Approved for entry into archive by Arlan Eloi Leite Silva (eloihistoriador@yahoo.com.br) on 2017-10-16T20:46:40Z (GMT) No. of bitstreams: 1 RafaelDosSantosDeBessa_DISSERT.pdf: 5392283 bytes, checksum: e272b2b1fcdcb6eb2e291aaaead851c7 (MD5) / Made available in DSpace on 2017-10-16T20:46:40Z (GMT). No. of bitstreams: 1 RafaelDosSantosDeBessa_DISSERT.pdf: 5392283 bytes, checksum: e272b2b1fcdcb6eb2e291aaaead851c7 (MD5) Previous issue date: 2016-08-30 / A epilepsia do lobo temporal (ELT) ? a forma mais frequente de epilepsia em adultos, caracterizada clinicamente por um quadro progressivo de crises epil?pticas com foco no lobo temporal, em particular no hipocampo. Dentre os modelos animais, os mais utilizados na investiga??o dos mecanismos fisiopatol?gicos desta condi??o geram crises recorrentes espont?neas atrav?s da indu??o inicial de um estado convulsivo sustentado (status epilepticus, SE) ? por administra??o do agonista glutamat?rgico ionotr?pico, ?cido ca?nico (AC) ou do agonista colin?rgico muscar?nico, pilocarpina (PILO). Entretanto, o uso de inje??es sist?micas e a falta de controle preciso sobre a dura??odo SE geram alta mortalidade, morte celular dispersa e grande variabilidade comportamental durante a fase cr?nica da epilepsia, o que difere em v?rios aspectos do quadro humano. A nosso ver, este padr?o decorre da a??o sist?mica da droga e da dificuldade de controlar a atividade eletrogr?fica/tempo de SE a que cada animal ? submetido, influenciando a din?mica da epileptog?nese. Portanto, este projeto teve como objetivo gerar modelos de ELT por infus?o intra-hipocampal de AC e PILO em ratos e analisar seus comportamentos e atividade eletrofisiol?gica durante o SE. Vale ressaltar que ainda n?o h? estudos eletrofisiol?gicos aprofundados sobre o modelo de PILO intra-hipocampal. Para isto, implantamos feixes de microeletrodos bilateralmente no hipocampo e unilateralmente no c?rtex pr?-frontal medial (CPFm), junto a uma c?nula no hipocampo ventral para infus?o de AC ou PILO. Ap?s a indu??o do SE analisamos a progress?o comportamental e eletrofisiol?gica dos animais. O SE foi bloqueado ap?s 2h por um coquetel anti-convulsivante mais potente do que o utilizado na maioria dos estudos atuais e os animais foram acompanhados por registros cont?nuos de v?deo-EEG sincronizado por at? 72h. Sete dias ap?s o SE, os animais foram sacrificados e seus c?rebros retirados para verifica??o histol?gica da posi??o da c?nula e eletrodos. Os registros de v?deo e de EEG foram analisados por inspe??o visual e t?cnicas de an?lise de s?ries temporais. Nossos resultados mostraram que os animais PILO apresentam 1a crise comportamental com menor lat?ncia do que os animais tratados com AC, por?m com severidade mais vari?vel (AC: 90% animais classe 1 vs. PILO: 50% animais ?classe 3, escala de Racine). Animais PILO tamb?m tiveram menor n?mero de comportamentos do tipo wet-dog shakes que os animais AC, associado a um in?cio de SE precoce comparado aos animais AC. Do ponto de vista eletrofisiol?gico, observamos oscila??es de alta frequ?ncia (>150 Hz), comumente observadas na fase cr?nica da epilepsia, logo ap?s a inje??o de ambos convulsivantes (15-40 min antes do in?cio do SE) concomitante ?s primeiras crises eletrogr?ficas. Por fim, identificamos que o SE em ambos modelos exibe uma organiza??o modular da atividade parox?stica com v?rios n?veis de ritmicidade sobrepostos. Nossos resultados indicam uma maior epileptogenicidade da PILO em rela??o ao AC e, que estas drogas produzem SE com din?micas distintas. Pudemos observar uma composi??o com m?dulos de oscila??es sobrepostas repetidos periodicamente, m?dulos de hipersincronia sem oscila??es acopladas e segmentos de atividade ass?ncrona. Nossos dados ressaltam a import?ncia do registro eletrogr?fico durante o SE para melhor controlar as respostas individuais durante este per?odo. / Temporal lobe epilepsy (TLE) is the most common form of epilepsy in adults. It is characterized by a progressive occurrence of epileptic seizures originating in the temporal lobe, particularly in the hippocampal formation (mesial TLE). Among the animal models used to investigate the physiopathological mechanisms of TLE, the most used are those that lead to spontaneous seizures after an initial insult, such as a prolonged convulsive state (status epilepticus, SE). This condition can be induced by the administration of the glutamatergic agonist, kainic acid (KA) or the cholinergic agonist, pilocarpine (PILO). However, the use of systemic injections and the lack of electrophysiological monitoring during SE lead to high mortality rates, widespread cell death and high behavioral variability during the chronic phase of epilepsy, which differs in several aspects from the human condition. These effects are mainly due to the lack of electrographic control of SE duration and the dynamics of the epileptogenesis process during the weeks following SE. Therefore, this project aimed to generate two animal models of TLE by intra-hippocampal injections of KA or PILO, and then, to analyze their behavioral and electrographic progression during SE. It is important to notice that no electrophysiological study has investigated the SE dynamics in animals infused with PILO into hippocampus so far. For that, we implanted two bundles of microelectrodes in the hippocampus bilaterally, one bundle in the medial prefrontal cortex and a cannula above the intermediate hippocampus for KA or PILO infusion. Following SE induction, we analyzed the behavioral and electrophysiological evolution of KA and PILO animals. SE was blocked after 2h by the injection of an anti-convulsant cocktail and the animals were continuously monitored by video-EEG for up to 72h. Seven days after SE, animals underwent euthanasia and had the brains removed for histological localization of cannula and electrodes. Video and EEG recordings were analyzed by visual inspection and spectral decomposition. Our results showed that PILO animals had shorter latency for first behavioral seizure than KA rats after drug injection. However, seizure severity showed higher variability among PILO rats (PILO: 50% animals had class 3 or higher vs. KA: 90% animals had class 1; Racine?s scale). PILO animals had a reduced number of wet-dog shake behaviors and shorter latency to SE onset as compared to KA rats. Electrophysiologically, we observed that high frequency oscillations (>150 Hz) occurred short after the injection of both drugs (15-40min before SE onset), as opposed to what is commonly reported to occur during the chronic phase of epilepsy in rodents. They were usually found within the first electrographic seizures. Finally, we have identified a distinct modular organization of paroxystic activity during the SE in each group, which consisted of blocks of nested rhythms. These findings thus suggest that PILO is more epileptogenic that KA and that these drugs produce distinct SE dynamics, which seem to be organized as periodically repeating modules of nested oscillations, modules of hyper synchrony with no nested oscillations and segments of asynchronous activity. Our data emphasizes the importance to conduct electrophysiological recordings during SE induction in order to better control individual brain responses. This can reduce variability during epileptogenesis and produce a more homogeneous model of chronic epilepsy.

<p>Epilepsy is comorbid with cognitive and psychiatric dysfunctions. This pathophysiology, associated with hippocampal synaptodendritic structural and functional changes, is exacerbated by prolonged seizures (status epilepticus; SE). We found a correlation between hippocampal dendritic loss and microgliosis after SE, along with hyperactivation of the classical complement pathway (C1q-C3). These paralleled increased seizure frequency and memory deficits in a rat model of SE and acquired epilepsy. C1q leads to C3 cleavage into biologically active fragments C3a and C3b. Evidence suggests that C1q and C3b contribute to synaptic stripping by microglia in the developing brain and neurodegenerative disorders. Thus, we hypothesized that SE-induced C3 activation may alter hippocampal synaptic protein levels thereby promoting memory deficits. </p> <p>To test the hypothesis, different groups of wild type (WT) or C3 deficient (C3KO) mice were injected with pilocarpine (350mg/kg) to induce SE or saline (controls): WT-C, WT-SE, C3KO-C, and C3KOSE. At two weeks after SE, mice were subjected to novel object recognition (NOR) to evaluate recognition memory, and Barnes maze (BM) to measure hippocampal-dependent spatial learning and memory. Following behavioral testing, mice were sacrificed and hippocampi collected at either 2 or 5 weeks after SE to measure changes in C3 protein levels and levels of synaptic proteins including PSD95, Vglut1, and Vgat. As a method of verifying our findings, we used a second model of pilocarpine-induced SE in male Sprague Dawley rats. Starting at 7 days after SE, rats were treated with cobra venom factor (CVF; 100ng/g, i.p.) or vehicle (veh) every third day. On days 14-15 rats were subjected to open field and NOR to measure anxiety and recognition memory. On day 16, rats were sacrificed and hippocampi collected for western blotting.</p> <p>WT and C3KO mice were able to reach stage 4.5-6 seizures after pilocarpine injections. In NOR trial 1, exploration time for both objects was similar in all groups (<i>p</i> > .05). In trial 2, WT-C and C3KO-C mice spent more time exploring the novel object than the familiar one (<i>p</i> < .05) while WT-SE mice explored both objects equally (<i>p</i> > .05). Interestingly, C3KO-SE mice spent more time with the novel object similar to controls (<i>p</i> > .05), suggesting that the deficit in object recognition memory induced by SE was attenuated in C3KO mice. Similarly, veh- and CVF-treated control rats spent more time exploring the novel object during trial 2 (<i>p</i> < .05). The veh-treated SE rats did not show significant preference for the novel object versus familiar (<i>p</i> > .05), whereas the CVF-treated SE rats explored the novel object significantly more than the familiar (p < .05). These findings support that C3 inhibition after SE prevents recognition memory deficits. Furthermore, there was a reduction in synaptic proteins PSD95 and Vgat in the SE-veh group compared to the C-veh group. This difference was not observed in the C-CVF and SE-CVF groups, suggesting that blocking C3 after SE is neuroprotective against hippocampal synaptic loss.</p> <p>Taken together, these findings are the first to show an association between C3 activation and hippocampal and cognitive deficits in two rodent models of SE and acquired TLE. We found that depletion of C3 is sufficient to attenuate SE-induced deficits in NOR-evaluated recognition memory and changes in the levels of an inhibitory synaptic protein. In conclusion, our data suggest that SE-induced complement C3 activation contributes to hippocampal synaptic remodeling and impairments in recognition memory, and that the complement C3 may be a potential therapeutic target for the memory comorbidities associated with SE. Future studies will determine the effect of C3 inhibition on spontaneous recurrent seizures, and whether C3-guided and microglial-dependent phagocytosis is an underlying mechanism for the SE-induced epileptogenic synaptic remodeling.</p>

<p>Evidence from experimental models of epilepsy support that prolonged seizures (status epilepticus, SE) promote pathological hippocampal synaptodendritic remodeling which contributes to the development of seizures and cognitive decline. One potential mechanism underlying the SE-induced sequelae is microgliosis. </p> <p>Evidence from models of experimental epilepsy supports a significant spatiotemporal correlation between SE-induced decreases in the microtubule associated protein 2 (Map2) loss and microgliosis in the hippocampus. In addition, pharmacological suppression of microgliosis after SE with the drug rapamycin attenuated the losses of Map2 and the dendritic ion channels Kv.4.2 and HCN1 in the hippocampus. This microglia suppression paralleled a recovery of the SE-induced recognition and spatial memory deficits. Based on these studies, we hypothesized that the inhibition of microgliosis during epileptogenesis will attenuate the SE-induced hippocampal dendritic and cognitive pathology. To further investigate the role of microgliosis in the SE-induced dendritic pathology, we tested the efficacy of a more selective inhibitor <a>of the survival and proliferation of </a>microglia, PLX3397, using the pilocarpine model of SE and acquired epilepsy. PLX3397 binds to colony stimulating factor 1 receptor (CSF1R) on microglia and inhibits the downstream signaling responsible for survival and proliferation of these cells. </p> <p>To test this hypothesis, we induced SE in male rats with pilocarpine (280-300mg/kg) <a>while and controls (Ctrl) received saline. </a>Rats were randomly assigned to a diet of either chow alone (vehicle; Veh) or chow with PLX3397 (50mg/kg) for 20 days post-SE. At two weeks post-SE, rats were subjected to novel object recognition (NOR) and Barnes maze (BM) to evaluate hippocampal-dependent recognition memory, and spatial learning and memory, respectively. Following the behavioral assessments, rats were sacrificed for brain analysis at 20 days post-SE. We used histological analysis to determine the amount of microgliosis with IBA1 and dendritic stability with Map2. We used western blotting to measure the protein levels of molecules involved in the crosstalk between microglia and astrocytes: GFAP, IL-6, C3, and iC3b. We also measured the protein levels of the dendritic ion channels Kv4.2 and HCN1, and the synaptic marker PSD95.</p> <p>NOR showed that the Ctrl+Veh and Ctrl+PLX3397 groups spent significantly more time exploring the novel object (<i>p</i> < .05), while the SE+Veh and SE+PLX3397 did not. Similar results were observed in the BM test, Ctrl+Veh and Ctrl+PLX3397 groups had a faster latency to find the target compared to the SE+Veh and SE+PLX3397 groups (<i>p</i> < .05). These data suggest that recognition and spatial memory deficits induced by SE were not attenuated by treatment with PLX3397. We found that the PLX3397 treatment significantly decreased microgliosis in Ctrl+PLX3397 rats compared to Ctrl+Veh rats (<i>p</i> < .05). As expected, we found a significant increase in the number of microglial cells in hippocampi of SE+Veh rats compared to Ctrl+Veh rats (<i>p</i> < .05). Interestingly, in the PLX3397-treated SE group, we observed two distinctive groups which we categorized as responders and non-responders when compared to the SE+Veh group. The SE+PLX responders had significantly decreased microgliosis compared to the SE+Veh group (<i>p</i> < .05). The SE+PLX non-responders had higher levels of microgliosis compared to the SE+Veh group (<i>p</i> < .05). We found levels of GFAP were increased in the SE+Veh group compared to the Ctrl+Veh group (<i>p</i> < .05). Treatment with PLX3397 in the SE group reduced these levels compared to the vehicle treated SE group (<i>p</i> < .05). We also found increases in C3 and iC3b following the induction of SE compared to Ctrl+Veh group (<i>p</i> < .05), and these levels remained similar in the SE+PLX3397 group compare to the SE+Veh group (<i>p</i> > .05). There was a reduction in Map2 immunoreactivity as well as the protein levels of Kv4.2 and PSD95 in the SE+Veh group compared to the Ctrl+Veh group (<i>p</i> < .05). We found that treatment with PLX3397 recovered the SE-induced loss of Map2 labeled dendrites compared to SE+Veh group (<i>p</i> < .05). However, treatment with PLX3397 did not recover the SE-induced reduction Kv4.2 and PSD95 (<i>p</i> > .05). <a>In parallel, we found that a group of SE+PLX3397 animals did not have reduced microgliosis compared to the SE+Veh group (<i>p </i>< .05), and therefore was categorized as a non-responder group. </a></p> Our findings are the first to show that blocking CSF1R signaling with PLX3397 suppressed microgliosis in the hippocampus, partially recovered the SE-induced decline of Map2 immunoreactivity in the hippocampal CA1 region but had no effect in the recognition or spatial memory deficits. These data suggest that while hippocampal microgliosis may play a role in the disruption of dendritic structural stability in the hippocampus it does not seem to critically contribute to the memory decline that occurs during epileptogenesis.

京都大学 / 0048 / 新制・論文博士 / 博士(医学) / 乙第13125号 / 論医博第2134号 / 新制||医||1024(附属図書館) / (主査)教授 宮本 享, 教授 村井 俊哉, 教授 井上 治久 / 学位規則第4条第2項該当 / Doctor of Medical Science / Kyoto University / DFAM

No description available.

Organophosphates (OPs) are a major class of pesticides and nerve agents that elicit acute toxicity by inhibiting acetylcholinesterase (AChE), the enzyme responsible for the degradation of the neurotransmitter acetylcholine in the central and peripheral nervous systems. Acetylcholine accumulation following extensive AChE inhibition leads to an acute cholinergic syndrome characterized by autonomic dysfunction, involuntary movements, muscle fasciculations, respiratory distress, and seizures. Despite their classification as moderate to highly toxic, OP pesticides are the most widely used class of insecticides in the U.S., and are even more commonly used worldwide. Additionally, there is a growing concern that OP nerve agents could be used to cause mass civilian casualties. It is well known that the survivors of acute nerve gas poisoning and chronic OP pesticide exposure exhibit neurobehavioral deficits including mood changes, depression, and memory impairments. Despite this, there are very few treatments available for OP-intoxication survivors and this topic is under-researched. In this study we investigated whether animals surviving a single severe OP exposure exhibited long-term neurological impairments, using two OP agents: paraoxon (POX) and diisopropyl fluorophosphates (DFP), as well as a non-OP chemoconvulsant, pilocarpine (Pilo), which acts as a muscarinic agonist. Exposure to POX, DFP, or Pilo led to overt signs of cholinergic toxicity. POX and DFP rats were rescued with an optimized atropine, 2-PAM, and diazepam therapy per current OP-exposure treatment guidelines, while Pilo rats were given only diazepam. Saline was administered to control rats at all pharmacological timepoints. Surviving rats were studied using established behavioral assays for identifying symptoms of depression and memory impairment 3-6 months after exposure to toxic agents. In the forced swim test, POX, DFP, and Pilo animals exhibited increased immobility time indicative of a despair-like state. In the sucrose preference test, POX, DFP, and Pilo rats did not display a preference for sucrose water, indicating an anhedonia-like condition. POX, DFP, and Pilo rats also displayed increased anxiety as characterized by significantly lower performance in the open arm of the elevated plus maze. Furthermore, when tested with a novel object recognition paradigm, POX, DFP, and Pilo rats exhibited a significantly lower discrimination ratio, indicating impaired recognition memory. The results indicate that these models of survival from severe POX and DFP exposure can be employed to study chronic behavioral and cognitive comorbidities and to further investigate the molecular bases for these comorbidities, potentially leading to the development of pharmacological therapies.

These studies were completed to examine how status epilpeticus seizure characteristics are modulated during post-juvenile brain development. This may determine if postnatal age in rats is a better identifier of stages of post-juvenile brain development. The first study fully detailed the acute discrete seizure phase of the rat pilocarpine-SE model. Results for this study showed that Racine behavioral severity score, spike frequency, and seizure severity during the acute discrete seizure phase change in relation to post-juvenile brain developmental stages. The second study fully detailed early and late patterns of status epilepticus. Results for this study displayed modulation of time in pattern, spike frequency, and relative delta power for seizure pattern during post-juvenile ages. The third study displayed modulation of diazepam efficacy during post-juvenile ages. The data suggest characteristics in the acute discrete seizure pliase, chronic SE phase, and therapeutic window of SE change in relation to age during post-juvenile brain development. This establishes that age is a better estimator of developmental stage than animal bodyweight.